OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Toxicities From Antibody-Drug Conjugates	86
Social Drivers of Cancer Risk and Outcomes Among African American Men	44
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	37
PET Imaging of Metabolism, Perfusion, and Hypoxia	25
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	21
Oncology Physician Workforce Diversity	21
Individualizing Therapy for Malignant Gliomas	20
Health Care Policy and Disparities in Health	19
Clinical Evidence Generation During a Pandemic	19
Building a Bridge to Equity in Health and Health Care in Cancer Care	19
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	17
Stereotactic Body Radiation Therapy	17
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	15
Melanoma—Modern Treatment for Metastatic Melanoma	15
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	13
The Principles and Practice of PARP Inhibitor Therapy	13
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	13
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	12
Diversity in Cancer Care	12
Nonoperative Management for Rectal Cancer	12
Metastatic Melanoma Treatment in Special Populations	12
Prostate Cancer, Race, and Health Disparity	11
Antibody Drug Conjugates in Multiple Myeloma	11
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	11
Germline Predisposition to Myelodysplastic Syndromes	11

Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	10
Primary Prevention of Cancer	10
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	10
Clinical Targeting of Altered Metabolism in High-Grade Glioma	10
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	9
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	9
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	9
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas	9
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	9
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	8
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	8
DNA Damage Repair Inhibitors—Combination Therapies	8
Rectal Cancer—The Only Constant Is Change	8
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	8
Updates in the Management of Uveal Melanoma	7
Supportive Care for Patients With Myelodysplastic Syndromes	7
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	7
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	7
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	7
Telehealth and Technology	7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	7
New Metabolomic Insights Into Cancer	7
Introduction	7
Menopausal Hormone Therapy and Breast Cancer	7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	6
Impact of Precision Medicine in Oncology	6
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Hormone Replacement Therapy After Breast Cancer	6
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	6
Discovery of Natural Products for Cancer Prevention	6
How Far We’ve Come	6
Survival of the Fittest	6
Role of the Microbiome in Immunotherapy of Melanoma	6
Neurosurgical Advances for Malignant Gliomas	6
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	6